159 related articles for article (PubMed ID: 32772207)
1. Association Between Prescribed Hypnotics in Infants and Toddlers and Later ADHD: A Large Cohort Study from Norway.
Holdø I; Bramness JG; Handal M; Hansen BH; Hjellvik V; Skurtveit S
Child Psychiatry Hum Dev; 2021 Aug; 52(4):533-543. PubMed ID: 32772207
[TBL] [Abstract][Full Text] [Related]
2. Association of Maternal Use of Benzodiazepines and Z-Hypnotics During Pregnancy With Motor and Communication Skills and Attention-Deficit/Hyperactivity Disorder Symptoms in Preschoolers.
Lupattelli A; Chambers CD; Bandoli G; Handal M; Skurtveit S; Nordeng H
JAMA Netw Open; 2019 Apr; 2(4):e191435. PubMed ID: 30951155
[TBL] [Abstract][Full Text] [Related]
3. Association between prescribing hypnotics for parents and children in Norway.
Holdø I; Handal M; Skurtveit S; Bramness JG
Arch Dis Child; 2013 Sep; 98(9):732-6. PubMed ID: 23845695
[TBL] [Abstract][Full Text] [Related]
4. Association of Prenatal Exposure to Benzodiazepines and Z-Hypnotics With Risk of Attention-Deficit/Hyperactivity Disorder in Childhood.
Sundbakk LM; Gran JM; Wood ME; Handal M; Skurtveit S; Nordeng H
JAMA Netw Open; 2022 Dec; 5(12):e2246889. PubMed ID: 36520439
[TBL] [Abstract][Full Text] [Related]
5. ADHD treatment and diagnosis in relation to children's birth month: Nationwide cohort study from Norway.
Karlstad Ø; Furu K; Stoltenberg C; Håberg SE; Bakken IJ
Scand J Public Health; 2017 Jun; 45(4):343-349. PubMed ID: 28482754
[TBL] [Abstract][Full Text] [Related]
6. Child and Parental Characteristics of Medication Use for Attention-Deficit/Hyperactivity Disorder.
Oerbeck B; Furu K; Zeiner P; Aase H; Reichborn-Kjennerud T; Pripp AH; Overgaard KR
J Child Adolesc Psychopharmacol; 2020 Sep; 30(7):456-464. PubMed ID: 32672488
[No Abstract] [Full Text] [Related]
7. Prenatal exposure to non-steroidal anti-inflammatory drugs and risk of attention-deficit/hyperactivity disorder: A follow-up study in the Norwegian mother, father and child cohort.
Hjorth S; Lupattelli A; Handal M; Spigset O; Ystrom E; Nordeng H
Pharmacoepidemiol Drug Saf; 2021 Oct; 30(10):1380-1390. PubMed ID: 33866622
[TBL] [Abstract][Full Text] [Related]
8. Dispensation of attention deficit hyperactivity disorder (ADHD) medications in patients receiving opioid agonist therapy; a national prospective cohort study in Norway from 2015 to 2017.
Vold JH; Aas C; Skurtveit S; Odsbu I; Chalabianloo F; Halmøy A; Johansson KA; Fadnes LT
BMC Psychiatry; 2020 Mar; 20(1):119. PubMed ID: 32164615
[TBL] [Abstract][Full Text] [Related]
9. Association of Perinatal and Childhood Ischemic Stroke With Attention-Deficit/Hyperactivity Disorder.
Bolk J; Simatou E; Söderling J; Thorell LB; Persson M; Sundelin H
JAMA Netw Open; 2022 Apr; 5(4):e228884. PubMed ID: 35471571
[TBL] [Abstract][Full Text] [Related]
10. ADHD, comorbid disorders and psychosocial functioning: How representative is a child cohort study? Findings from a national patient registry.
Oerbeck B; Overgaard KR; Aspenes ST; Pripp AH; Mordre M; Aase H; Reichborn-Kjennerud T; Zeiner P
BMC Psychiatry; 2017 Jan; 17(1):23. PubMed ID: 28095819
[TBL] [Abstract][Full Text] [Related]
11. Medical treatment of children and youths with attention-deficit/hyperactivity disorder (ADHD): a Norwegian Prescription Registry Based Study.
Norum J; Olsen AI; Nohr FI; Heyd A; Totth A
Glob J Health Sci; 2014 Apr; 6(4):155-62. PubMed ID: 24999151
[TBL] [Abstract][Full Text] [Related]
12. Risk of hip fracture among older people using anxiolytic and hypnotic drugs: a nationwide prospective cohort study.
Bakken MS; Engeland A; Engesæter LB; Ranhoff AH; Hunskaar S; Ruths S
Eur J Clin Pharmacol; 2014 Jul; 70(7):873-80. PubMed ID: 24810612
[TBL] [Abstract][Full Text] [Related]
13. Prescriptions for ADHD medication, 2004-08.
Lillemoen PK; Kjosavik SR; Hunskår S; Ruths S
Tidsskr Nor Laegeforen; 2012 Sep; 132(16):1856-60. PubMed ID: 22986969
[TBL] [Abstract][Full Text] [Related]
14. Prescribing of drugs for attention-deficit hyperactivity disorder in opioid maintenance treatment patients in Norway.
Karlstad Ø; Furu K; Skurtveit S; Selmer R
Eur Addict Res; 2014; 20(2):59-65. PubMed ID: 24080771
[TBL] [Abstract][Full Text] [Related]
15. Association of Psychiatric Comorbidity With the Risk of Premature Death Among Children and Adults With Attention-Deficit/Hyperactivity Disorder.
Sun S; Kuja-Halkola R; Faraone SV; D'Onofrio BM; Dalsgaard S; Chang Z; Larsson H
JAMA Psychiatry; 2019 Nov; 76(11):1141-1149. PubMed ID: 31389973
[TBL] [Abstract][Full Text] [Related]
16. Early-life exposure to persistent organic pollutants (OCPs, PBDEs, PCBs, PFASs) and attention-deficit/hyperactivity disorder: A multi-pollutant analysis of a Norwegian birth cohort.
Lenters V; Iszatt N; Forns J; Čechová E; Kočan A; Legler J; Leonards P; Stigum H; Eggesbø M
Environ Int; 2019 Apr; 125():33-42. PubMed ID: 30703609
[TBL] [Abstract][Full Text] [Related]
17. Utilization of Stimulants and Atomoxetine for Attention-Deficit/Hyperactivity Disorder among 5.4 Million Children Using Population-Based Longitudinal Data.
Furu K; Karlstad Ø; Zoega H; Martikainen JE; Bahmanyar S; Kieler H; Pottegård A
Basic Clin Pharmacol Toxicol; 2017 Apr; 120(4):373-379. PubMed ID: 27911044
[TBL] [Abstract][Full Text] [Related]
18. Influence of relative age on diagnosis and treatment of attention-deficit/hyperactivity disorder in children.
Morrow RL; Garland EJ; Wright JM; Maclure M; Taylor S; Dormuth CR
CMAJ; 2012 Apr; 184(7):755-62. PubMed ID: 22392937
[TBL] [Abstract][Full Text] [Related]
19. Relative age within the school year and diagnosis of attention-deficit hyperactivity disorder: a nationwide population-based study.
Sayal K; Chudal R; Hinkka-Yli-Salomäki S; Joelsson P; Sourander A
Lancet Psychiatry; 2017 Nov; 4(11):868-875. PubMed ID: 29033006
[TBL] [Abstract][Full Text] [Related]
20. Early Predictors of ADHD: Evidence from a Prospective Birth Cohort.
Oerbeck B; Overgaard KR; Pripp AH; Reichborn-Kjennerud T; Aase H; Zeiner P
J Atten Disord; 2020 Oct; 24(12):1685-1692. PubMed ID: 29254401
[No Abstract] [Full Text] [Related]
[Next] [New Search]
